Berger, Carolina <br/><br/>
Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells.  [electronic resource] 

 -  Cancer immunology research  Feb 2015 
 - 206-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2326-6074 
<br/><br/><label>Standard No.: </label>10.1158/2326-6066.CIR-14-0163  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Movement--immunology<br/>Cell Survival--immunology<br/>Cytokines--blood<br/>Genetic Engineering--methods<br/>Genetic Vectors<br/>Humans<br/>Immunotherapy, Adoptive--adverse effects<br/>Macaca mulatta<br/>Models, Animal<br/>Receptor Tyrosine Kinase-like Orphan Receptors--metabolism<br/>Receptors, Antigen, T-Cell--genetics<br/>Retroviridae--genetics<br/>T-Lymphocytes--immunology<br/>Transduction, Genetic